Literature DB >> 17613534

Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.

Zhongwen Xie1, Ming C Gong, Wen Su, John Turk, Zhenheng Guo.   

Abstract

Rgs2 (regulator of G-protein signaling-2)-deficient mice exhibit severe hypertension, and genetic variations of RGS2 occur in hypertensive patients. RGS2 mRNA up-regulation by angiotensin II (Ang II) in vascular smooth muscle cells (VSMC) is a potentially important negative feedback mechanism in blood pressure homeostasis, but how it occurs is unknown. Here we demonstrate that group VIA phospholipase A2 (iPLA2beta) plays a pivotal role in Ang II-induced RGS2 mRNA up-regulation in VSMC by three independent approaches, including pharmacologic inhibition with a bromoenol lactone suicide substrate, suppression of iPLA2beta expression with antisense oligonucleotides, and genetic deletion in iPLA2beta-null mice. Selective inhibition of iPLA2beta by each of these approaches abolishes Ang II-induced RGS2 mRNA up-regulation. Furthermore, using adenovirus-mediated gene transfer, we demonstrate that restoration of iPLA2beta-expression in iPLA2beta-null VSMC reconstitutes the ability of Ang II to up-regulate RGS2 mRNA expression. In contrast, Ang II-induced vasodilator-stimulated phosphoprotein phosphorylation and Ang II receptor expression are unaffected. Moreover, in wild-type but not iPLA2beta-null VSMC, Ang II stimulates iPLA2 enzymatic activity significantly. Both arachidonic acid and lysophosphatidylcholine, products of iPLA2beta action, induce RGS2 mRNA up-regulation. Inhibition of lipoxygenases, particularly 15-lipoxygenase, and cyclooxygenases, but not cytochrome P450-dependent epoxygenases inhibits Ang II- or AA-induced RGS2 mRNA expression. Moreover, RGS2 protein expression is also up-regulated by Ang II, and this is attenuated by bromoenol lactone. Disruption of the Ang II/iPLA2beta/RGS2 feedback pathway in iPLA2beta-null cells potentiates Ang II-induced vasodilator-stimulated phosphoprotein and Akt phosphorylation in a time-dependent manner. Collectively, our results demonstrate that iPLA2beta participates in Ang II-induced transcriptional up-regulation of RGS2 in VSMC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613534      PMCID: PMC2096773          DOI: 10.1074/jbc.M611206200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling.

Authors:  Xiaoguang Sun; Kevin M Kaltenbronn; Thomas H Steinberg; Kendall J Blumer
Journal:  Mol Pharmacol       Date:  2004-11-24       Impact factor: 4.436

2.  Expression of regulator of G protein signalling proteins in natural killer cells, and their modulation by Ly49A and Ly49D.

Authors:  Lise Kveberg; James C Ryan; Bent Rolstad; Marit Inngjerdingen
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

3.  RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.

Authors:  Huan Pang; Zhenheng Guo; Wen Su; Zhongwen Xie; Masumi Eto; Ming C Gong
Journal:  Am J Physiol Cell Physiol       Date:  2005-04-06       Impact factor: 4.249

Review 4.  Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells.

Authors:  Jesús Balsinde; María A Balboa
Journal:  Cell Signal       Date:  2005-04-07       Impact factor: 4.315

5.  Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population.

Authors:  Jin Yang; Kei Kamide; Yoshihiro Kokubo; Shin Takiuchi; Chihiro Tanaka; Mariko Banno; Yoshikazu Miwa; Masayoshi Yoshii; Takeshi Horio; Akira Okayama; Hitonobu Tomoike; Yuhei Kawano; Toshiyuki Miyata
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

6.  Developmentally regulated expression of the regulator of G-protein signaling gene 2 (Rgs2) in the embryonic mouse pituitary.

Authors:  L D Wilson; S A Ross; D A Lepore; T Wada; J M Penninger; P Q Thomas
Journal:  Gene Expr Patterns       Date:  2005-02       Impact factor: 1.224

7.  Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation.

Authors:  Jin-Ho Kim; Yong-Ri Jin; Beoung-Soo Park; Tack-Joong Kim; Soo-Yeon Kim; Yong Lim; Jin-Tae Hong; Hwan-Soo Yoo; Yeo-Pyo Yun
Journal:  Biochem Pharmacol       Date:  2005-06-15       Impact factor: 5.858

8.  RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

Authors:  Joachim Schwäble; Chunaram Choudhary; Christian Thiede; Lara Tickenbrock; Bülent Sargin; Claudia Steur; Maike Rehage; Annika Rudat; Christian Brandts; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve
Journal:  Blood       Date:  2004-11-09       Impact factor: 22.113

9.  Genetic and pharmacologic evidence that calcium-independent phospholipase A2beta regulates virus-induced inducible nitric-oxide synthase expression by macrophages.

Authors:  Jason M Moran; R Mark L Buller; Jane McHowat; John Turk; Mary Wohltmann; Richard W Gross; John A Corbett
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

10.  Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.

Authors:  Yuan Li; Shehla Hashim; Madhu B Anand-Srivastava
Journal:  Cardiovasc Res       Date:  2005-03-05       Impact factor: 10.787

View more
  33 in total

1.  Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhongwen Xie; Zhenheng Guo; Marilyn J Duncan; Jenny Lutshumba; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

Review 2.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

3.  Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse.

Authors:  Janhavi Sharma; John Turk; Jane McHowat
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

4.  Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.

Authors:  Jane McHowat; Gail Gullickson; Richard G Hoover; Janhavi Sharma; John Turk; Jacki Kornbluth
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-12       Impact factor: 4.249

5.  Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholine.

Authors:  Hans H Dietrich; Dana R Abendschein; Sung Ho Moon; Neema Nayeb-Hashemi; David J Mancuso; Christopher M Jenkins; Kevin M Kaltenbronn; Kendall J Blumer; John Turk; Richard W Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

6.  Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.

Authors:  Zhongwen Xie; Dexiang Liu; Shu Liu; Lindsay Calderon; Guogang Zhao; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

7.  Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation.

Authors:  Zhongwen Xie; Wen Su; Shu Liu; Guogang Zhao; Karyn Esser; Elizabeth A Schroder; Mellani Lefta; Harald M Stauss; Zhenheng Guo; Ming Cui Gong
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

8.  Role of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; Dongping Xie; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

9.  Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

Authors:  Sasanka Ramanadham; Kevin E Yarasheski; Matthew J Silva; Mary Wohltmann; Deborah Veis Novack; Blaine Christiansen; Xiaolin Tu; Sheng Zhang; Xiaoyong Lei; John Turk
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

10.  Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhenheng Guo; David C Randall; Lisa Cassis; David R Brown; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.